longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Restart Life Sciences Becomes Revenue Producer With Holy Crap Foods Acquisition

Tip Ranks
Feb 27, 2026 at 02:21 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

Restart Life Sciences has acquired Holy Crap Foods Inc., gaining 100% ownership of the functional cereal brand and its assets, which adds over $1 million in annual revenue. This acquisition allows Restart Life to become a revenue-producing organization and control a manufacturing facility in Gibsons, B.C. The company plans to leverage Holy Crap’s established customer base for expansion in the health and wellness sector. The latest analyst rating for Stuhini Exploration (TSE:NOVA) is a Hold with a price target of C$0.21, reflecting concerns over financial performance despite some positive technical indicators.

Claim 50% Off TipRanks Premium

  • Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
  • Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Stuhini Exploration ( (TSE:NOVA) ) has provided an update.

Restart Life Sciences has closed its acquisition of Holy Crap Foods Inc., securing 100% ownership of the functional cereal brand and its related assets, including intellectual property, inventory, and longstanding retail and distributor relationships. The deal immediately adds more than $1 million in annualized revenue and makes Restart Life a revenue-producing organization.

The transaction also gives Restart Life control of Holy Crap’s turnkey manufacturing facility in Gibsons, B.C., providing scalable production capacity while limiting new capital spending. Management plans to maintain existing operations, collaborate with Holy Crap’s team, and use the brand’s established customer base and in-house production as a platform to expand distribution, improve efficiencies, and pursue new product development in the health and wellness sector.

The most recent analyst rating on (TSE:NOVA) stock is a Hold with a C$0.21 price target. To see the full list of analyst forecasts on Stuhini Exploration stock, see the TSE:NOVA Stock Forecast page.

Spark’s Take on TSE:NOVA Stock

According to Spark, TipRanks’ AI Analyst, TSE:NOVA is a Neutral.

The score is held down primarily by weak financial performance (no revenue, persistent losses, and ongoing cash burn), with valuation also constrained by negative earnings (negative P/E). These negatives are partially offset by favorable technicals (price above key moving averages with positive momentum) and a low-leverage balance sheet with no debt.

To see Spark’s full report on TSE:NOVA stock, click here.

More about Stuhini Exploration

Restart Life Sciences Corp. is a health and wellness company that is transitioning into a revenue-generating business through branded consumer products. Its focus now includes natural functional foods, with a newly acquired portfolio centred on the Holy Crap cereal brand, supported by in-house manufacturing and established retail and direct-to-consumer channels.

Average Trading Volume: 89,403

Technical Sentiment Signal: Hold

Current Market Cap: C$9.74M

See more data about NOVA stock on TipRanks’ Stock Analysis page.

Login to unlock1,896characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Recommended Readings

  • Apr 20, 2026 at 06:34 PMEli Lilly Announces $7 Billion Acquisition of Kelonia: Pioneering the 'In Vivo CAR-T' Frontier and Leading Gene Therapy …
  • Apr 16, 2026 at 11:12 AMUS Stocks Hit New Highs, Retail Investors Miss Out en masse: Tom Lee Says Next Rally Will Be Led by Them
  • Apr 7, 2026 at 10:32 PMReminder: Key events to watch intraday (all times Beijing Time)
  • Apr 1, 2026 at 11:11 PMEli Lilly's Oral Weight-Loss Drug Foundayo Approved, the Only One That Can Be Taken Anytime Without Fasting
  • Mar 31, 2026 at 04:47 PMDow Surges Over 1,000 Points, Nasdaq Rises Over 3.3%, Semiconductor Index Up 5%

Related Stocks

Biolife4d Corp

Biolife4d Corp

USSAVU

ReShape Lifesciences

ReShape Lifesciences

USRSLS

180 LIFE SCIENCES CORP C/WTS 07/11/2025(TO PUR COM)

180 LIFE SCIENCES CORP C/WTS 07/11/2025(TO PUR COM)

USATNFW

LongbridgeAI